Acetylcholinesterase Inhibitors: Start Low or Risk Going Slow?

Affiliations

¹ Division of Geriatric and Palliative Medicine, McGovern Medical School, Houston, TX.
² Department of Pharmacy Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX.

Editorial

Holly M Holmes et al. J Am Geriatr Soc. 2018 Sep.

. 2018 Sep;66(9):1663-1664.

doi: 10.1111/jgs.15499. Epub 2018 Aug 11.

¹ Division of Geriatric and Palliative Medicine, McGovern Medical School, Houston, TX.
² Department of Pharmacy Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX.

No abstract available

Comment on

Cardiovascular Outcomes of Cholinesterase Inhibitors in Individuals with Dementia: A Meta-Analysis and Systematic Review.
Isik AT, Soysal P, Stubbs B, Solmi M, Basso C, Maggi S, Schofield P, Veronese N, Mueller C. Isik AT, et al. J Am Geriatr Soc. 2018 Sep;66(9):1805-1811. doi: 10.1111/jgs.15415. Epub 2018 May 30. J Am Geriatr Soc. 2018. PMID: 29851022
Initial Cholinesterase Inhibitor Therapy Dose and Serious Events in Older Women and Men.
Rochon PA, Gruneir A, Gill SS, Wu W, Zhu L, Herrmann N, Bell CM, Austin PC, Stall NM, McCarthy L, Giannakeas V, Alberga A, Seitz DP, Normand SL, Gurwitz JH, Bronskill SE. Rochon PA, et al. J Am Geriatr Soc. 2018 Sep;66(9):1692-1699. doi: 10.1111/jgs.15442. Epub 2018 Jul 18. J Am Geriatr Soc. 2018. PMID: 30019755